Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentosan Polysulfate Sodium (Zilosul) in Knee Osteoarthritis
NCT04809376Phase 3Active, not recruiting
- Sponsor
- Paradigm Biopharmaceuticals
- Start
- Oct 2021
- Primary completion
- Oct 2024
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pentosan polysulfate sodium in osteoarthritis (OA), sponsored by Paradigm Biopharmaceuticals. Started Oct 2021; status: active, not recruiting.
02
Drugs
pentosan polysulfate sodium
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04809376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04809376.